Cargando…
The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
BACKGROUND: MicroRNAs (miRNAs) can serve as tumor suppressors and might provide an efficient strategy for annihilating tumor cells. Nevertheless, the potential role of miR-325 in hepatocellular carcinoma (HCC) is still unknown. METHODS: Using RT-PCR, immunoblots invasion assays and bioinformatics st...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509766/ https://www.ncbi.nlm.nih.gov/pubmed/26194496 http://dx.doi.org/10.1186/s13000-015-0323-z |
_version_ | 1782382079558811648 |
---|---|
author | Li, Huifen Huang, Weihua Luo, Rongcheng |
author_facet | Li, Huifen Huang, Weihua Luo, Rongcheng |
author_sort | Li, Huifen |
collection | PubMed |
description | BACKGROUND: MicroRNAs (miRNAs) can serve as tumor suppressors and might provide an efficient strategy for annihilating tumor cells. Nevertheless, the potential role of miR-325 in hepatocellular carcinoma (HCC) is still unknown. METHODS: Using RT-PCR, immunoblots invasion assays and bioinformatics strategies, we investigated the potential role of miR-325 in HCC. RESULTS: We showed that miR-325 was decreased and HMGB1 was increased in 99 patients with hepatocellular carcinoma. MiR-325 inhibition promoted cell invasion and proliferation, while miR-325 upregulation inhibited cell invasion and proliferation by using transwell and CCK8 assays. We further showed that HMGB1 might be a direct target of miR-325 and is negatively regulated by miR-325. Down-regulation of miR-325 predicts poor prognosis for HCC patients. CONCLUSIONS: These findings implied that miR-325 regulates cell invasion and proliferation via targeting HMGB1 and may be a potential prognostic marker for HCC. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/4655707031717989 |
format | Online Article Text |
id | pubmed-4509766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45097662015-07-23 The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1 Li, Huifen Huang, Weihua Luo, Rongcheng Diagn Pathol Research BACKGROUND: MicroRNAs (miRNAs) can serve as tumor suppressors and might provide an efficient strategy for annihilating tumor cells. Nevertheless, the potential role of miR-325 in hepatocellular carcinoma (HCC) is still unknown. METHODS: Using RT-PCR, immunoblots invasion assays and bioinformatics strategies, we investigated the potential role of miR-325 in HCC. RESULTS: We showed that miR-325 was decreased and HMGB1 was increased in 99 patients with hepatocellular carcinoma. MiR-325 inhibition promoted cell invasion and proliferation, while miR-325 upregulation inhibited cell invasion and proliferation by using transwell and CCK8 assays. We further showed that HMGB1 might be a direct target of miR-325 and is negatively regulated by miR-325. Down-regulation of miR-325 predicts poor prognosis for HCC patients. CONCLUSIONS: These findings implied that miR-325 regulates cell invasion and proliferation via targeting HMGB1 and may be a potential prognostic marker for HCC. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/4655707031717989 BioMed Central 2015-07-22 /pmc/articles/PMC4509766/ /pubmed/26194496 http://dx.doi.org/10.1186/s13000-015-0323-z Text en © Li et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Li, Huifen Huang, Weihua Luo, Rongcheng The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1 |
title | The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1 |
title_full | The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1 |
title_fullStr | The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1 |
title_full_unstemmed | The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1 |
title_short | The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1 |
title_sort | microrna-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509766/ https://www.ncbi.nlm.nih.gov/pubmed/26194496 http://dx.doi.org/10.1186/s13000-015-0323-z |
work_keys_str_mv | AT lihuifen themicrorna325inhibitshepatocellularcarcinomaprogressionbytargetinghighmobilitygroupbox1 AT huangweihua themicrorna325inhibitshepatocellularcarcinomaprogressionbytargetinghighmobilitygroupbox1 AT luorongcheng themicrorna325inhibitshepatocellularcarcinomaprogressionbytargetinghighmobilitygroupbox1 AT lihuifen microrna325inhibitshepatocellularcarcinomaprogressionbytargetinghighmobilitygroupbox1 AT huangweihua microrna325inhibitshepatocellularcarcinomaprogressionbytargetinghighmobilitygroupbox1 AT luorongcheng microrna325inhibitshepatocellularcarcinomaprogressionbytargetinghighmobilitygroupbox1 |